Label Changes for:

Victoza (Liraglutide [rDNA origin]) Injection

December 2012

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)


December 2012



  • Allergic reactions: rash and pruritus


December 2010


Adverse Reactions

Clinical Trials Experience
  • Infomration added to section based on trial reports, Liraglutide Effect and Action in Diabetes (LEAD-6): Effect on glycemic control of liraglutide or exenatide added to metformin, sulphonylurea or a combination of both in subjects with type 2 diabetes.